Cargando…

Integrating genetic mutations and expression profiles for survival prediction of lung adenocarcinoma

BACKGROUND: Lung adenocarcinoma (LUAD) is a set of heterogeneous diseases with distinct genetic and transcriptomic characteristics. Since the introduction of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society histologic classificati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Yueqiang, Chen, Donglai, Zhang, Xi, Luo, Yuping, Li, Siguang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501026/ https://www.ncbi.nlm.nih.gov/pubmed/30993904 http://dx.doi.org/10.1111/1759-7714.13072

Ejemplares similares

Genome-Wide Analysis of Lung Adenocarcinoma Identifies Novel Prognostic Factors and a Prognostic Score
por: Chen, Donglai, et al.
Publicado: (2019)

Combining Genetic Mutation and Expression Profiles Identifies Novel Prognostic Biomarkers of Lung Adenocarcinoma
por: Liu, Yun, et al.
Publicado: (2020)

Integrated Oncogenomic Profiling of Copy Numbers and Gene Expression in Lung Adenocarcinomas without EGFR Mutations or ALK Fusion
por: Luo, Yanzhuo, et al.
Publicado: (2018)

An expression signature model to predict lung adenocarcinoma-specific survival
por: Shi, Xiaoshun, et al.
Publicado: (2018)

EPHA5 mutations predict survival after immunotherapy in lung adenocarcinoma
por: Chen, Zhiming, et al.
Publicado: (2020)

Histopathological Images and Multi-Omics Integration Predict Molecular Characteristics and Survival in Lung Adenocarcinoma
por: Chen, Linyan, et al.
Publicado: (2021)

Increased GOLM1 Expression Independently Predicts Unfavorable Overall Survival and Recurrence-Free Survival in Lung Adenocarcinoma
por: Liu, Xi, et al.
Publicado: (2018)

Decreased HLF Expression Predicts Poor Survival in Lung Adenocarcinoma
por: Wang, Zaiyan, et al.
Publicado: (2021)

Mutation-Derived Long Noncoding RNA Signature Predicts Survival in Lung Adenocarcinoma
por: Yang, Longjun, et al.
Publicado: (2022)

Integrated expression profiles analysis reveals novel predictive biomarker in pancreatic ductal adenocarcinoma
por: Li, Hongzhe, et al.
Publicado: (2017)

The transcriptional landscape and mutational profile of lung adenocarcinoma
por: Seo, Jeong-Sun, et al.
Publicado: (2012)

Survival Benefit and Genetic Profile of Pemetrexed as Initial Chemotherapy in Selected Chinese Patients With Advanced Lung Adenocarcinoma
por: Guo, Long-Hua, et al.
Publicado: (2020)

Prognostic prediction of lung adenocarcinoma by integrative analysis of RHOH expression and methylation
por: Kuang, Muyu, et al.
Publicado: (2023)

Long noncoding RNA CCDC144NL-AS1 knockdown induces naïve-like state conversion of human pluripotent stem cells
por: Wang, Yingying, et al.
Publicado: (2019)

Genome-wide analyses of retrogenes derived from the human box H/ACA snoRNAs
por: Li, Yuping Luo and Siguang
Publicado: (2007)

Immune Profiling of Parkinson’s Disease Revealed Its Association With a Subset of Infiltrating Cells and Signature Genes
por: Zhang, Xi, et al.
Publicado: (2021)

Characterization of Tumor Microenvironment in Lung Adenocarcinoma Identifies Immune Signatures to Predict Clinical Outcomes and Therapeutic Responses
por: Chen, Donglai, et al.
Publicado: (2021)

A Nomogram Integrating Ferroptosis- and Immune-Related Biomarkers for Prediction of Overall Survival in Lung Adenocarcinoma
por: Chai, Mengyu, et al.
Publicado: (2021)

A methylation-based nomogram for predicting survival in patients with lung adenocarcinoma
por: Wang, Xuelong, et al.
Publicado: (2021)

An integrative analysis of DNA methylation and gene expression to predict lung adenocarcinoma prognosis
por: Xu, Liexi, et al.
Publicado: (2022)

MicroRNA expression profiles predict progression and clinical outcome in lung adenocarcinoma
por: Lin, Kang, et al.
Publicado: (2016)

Unique microRNA-profiles in EGFR-mutated lung adenocarcinomas
por: Bjaanæs, Maria Moksnes, et al.
Publicado: (2014)

Gene expression profiling analysis of lung adenocarcinoma
por: Xu, H., et al.
Publicado: (2016)

Distinct gene mutation profiles among multiple and single primary lung adenocarcinoma
por: Wang, Yadong, et al.
Publicado: (2022)

Aberrant CpG‐methylation affects genes expression predicting survival in lung adenocarcinoma
por: He, Wei, et al.
Publicado: (2018)

Lipid Metabolism is the common pathologic mechanism between Type 2 Diabetes Mellitus and Parkinson's disease
por: Zhang, Xi, et al.
Publicado: (2020)

Expression of calcium sensing receptor and E-cadherin correlated with survival of lung adenocarcinoma
por: Wen, Liyuan, et al.
Publicado: (2015)

Genetic dissection of intratumor heterogeneity of PD‐L1 expression in EGFR ‐mutated lung adenocarcinoma
por: Kunimasa, Kei, et al.
Publicado: (2023)

CDCA2 promotes lung adenocarcinoma cell proliferation and predicts poor survival in lung adenocarcinoma patients
por: Shi, Run, et al.
Publicado: (2017)

Lipid metabolism gene-wide profile and survival signature of lung adenocarcinoma
por: Li, Jinyou, et al.
Publicado: (2020)

Genetic mutation profiles and immune microenvironment analysis of pulmonary enteric adenocarcinoma
por: Xie, Min, et al.
Publicado: (2022)

Predicting the Lung Adenocarcinoma and Its Biomarkers by Integrating Gene Expression and DNA Methylation Data
por: Qiu, Wang-Ren, et al.
Publicado: (2022)

Integrative analysis of TP53 mutations in lung adenocarcinoma for immunotherapies and prognosis
por: Li, He, et al.
Publicado: (2023)

An oncogenic CTNNB1 mutation is predictive of post-operative recurrence-free survival in an EGFR-mutant lung adenocarcinoma
por: Kim, Yeseul, et al.
Publicado: (2023)

Overexpression of APC11 predicts worse survival in lung adenocarcinoma
por: Zhou, Jiayu, et al.
Publicado: (2018)

Immunoscore Predicts Survival in Early-Stage Lung Adenocarcinoma Patients
por: Zhao, Zihuan, et al.
Publicado: (2020)

Intratumoral immunoglobulin isotypes predict survival in lung adenocarcinoma subtypes
por: Isaeva, O. I., et al.
Publicado: (2019)

An Immune-Related Signature Predicts Survival in Patients With Lung Adenocarcinoma
por: Zhang, Minghui, et al.
Publicado: (2019)

A novel necroptosis signature for predicting survival in lung adenocarcinoma
por: Zang, Kui, et al.
Publicado: (2023)

Expression of Tiam1 predicts lymph node metastasis and poor survival of lung adenocarcinoma patients
por: Liu, Shuguang, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_cqa9br3765q3fhqo8vbefo1hr7